Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03429075

Organisation Name: Imperial College London

Overal Status: Active, not recruiting

Start Date: January 7, 2019

Last Update: July 31, 2020

Lead Sponsor: Imperial College London

Brief Summary: This is a randomised double-blind clinical trial. The aim is to compare the efficacy and mechanisms of action of psilocybin, the primary psychoactive substance in 'magic mushrooms', with the SSRI (selective serotonin reuptake inhibitor) escitalopram for major depressive disorder (MDD).

Conditions:
  • Depressive Disorder, Major


Total execution time in seconds: 0.15960288047791